Half-year Report
RNS Number : 0896A
Baronsmead Second Venture Trust PLC
27 May 2021
 

Baronsmead Second Venture Trust plc

Half-yearly report for the six months ended 31 March 2021

 

The Directors of Baronsmead Second Venture Trust plc are pleased to announce the unaudited half-yearly financial report for the six months to 31 March 2021. Copies of the half-yearly report can be obtained from the following website: www.baronsmeadvcts.co.uk.

Our Investment Objective

·      Baronsmead Second Venture Trust plc is a tax efficient listed company which aims to achieve long-term investment returns for private investors, including tax free dividends.

Investment Policy

·      To invest primarily in a diverse portfolio of UK growth businesses, whether unquoted or traded on AIM.

·      Investments are made selectively across a range of sectors in companies that have the potential to grow and enhance their value.

Dividend Policy

·   The Board will, wherever possible, seek to pay two dividends to Shareholders in each calendar year, typically an interim dividend in September and a final dividend following the Annual General Meeting in February/March;

·    The Board will use, as a guide, when setting the dividends for a financial year, a sum representing 7 per cent of the opening NAV of that financial year.

 

Key elements of the business model

Access to an attractive, diverse portfolio
Baronsmead Second Venture Trust plc gives shareholders access to a diverse portfolio of growth businesses.

 

The Company will make investments in growth businesses, whether unquoted or traded on AIM, which are substantially based in the UK in accordance with the prevailing VCT legislation. Investments are made selectively across a range of sectors.

 

The Manager's approach to investing
The Manager endeavours to select the best opportunities and applies a distinctive selection criteria based on:

 

·       Primarily investing in parts of the economy which are experiencing long-term structural growth.

·       Businesses that demonstrate, or have the potential for, market leadership in their niche.

·       Management teams that can develop and deliver profitable and sustainable growth.

·       Companies with the potential to become an attractive asset appealing to a range of buyers at the appropriate time to sell.

 

In order to ensure a strong pipeline of opportunities, the Manager invests in building deep sector knowledge and networks and undertakes significant proactive marketing to interesting target companies in preferred sectors. This approach generates a network of potentially suitable businesses with which the Manager maintains a relationship ahead of possible investment opportunities.

 

The Manager as an influential shareholder
The Manager is an engaged and supportive shareholder (on behalf of the Company) in both unquoted and significant quoted investments. For unquoted investments, representatives of the Manager often join the investee board. The role of the Manager with investees is to ensure that strategy is clear, the business plan can be implemented and that the management resources are in place to deliver profitable growth. The intention is to build on the business model and grow the company into an attractive target able to be either sold or potentially floated in the medium term.

 

Financial Highlights

+18.4% Net Asset Value (NAV) per share increased 18.4 per cent. to 83.1p in the six months to 31 March 2021, before deduction of dividends.

 

371.9p NAV total return to shareholders for every 100.0p invested at launch (January 2001).

 

£9.9m Realised proceeds in the period, returning 3.0x cost.

 

£32.4m Funds raised in the period (before costs).

 

 

Cash returned to shareholders

 

The table below shows the cash returned to shareholders that invested in Baronsmead Second Venture Trust plc dependent on their subscription cost, including tax available to be reclaimed on the subscription.

Year subscribed

Cash invested

(p)

Income tax reclaim

(p)

 

Net cash invested

(p)

Cumulative dividends

paid#

 (p)

Return on cash invested# (%)

2001 (January)

100.0

20.0

80.0

150.8

170.8

2005 (March) - C share*

100.0

40.0

60.0

107.6

147.6

2010 (March)

103.1

30.9

72.2

102.5

129.4

2012 (December)

117.4

35.2

82.2

84.5

102.0

2014 (March)

112.4

33.7

78.7

64.5

87.4

2016 (February)

107.2

32.2

75.0

48.0

74.8

2017 (October)

97.5

29.2

68.2

28.0

58.7

2019 (February)

85.3

25.6

59.7

20.5

54.0

2019 (November)

78.9

23.7

55.2

13.0

46.5

2020 (January)

84.8

25.4

59.4

13.0

45.3

2020 (February)

82.5

24.8

57.7

9.5

41.6

2020 (March)

64.3

19.3

45.0

9.5

44.8

2020 (November)

77.9

23.4

54.5

6.5

38.4

2020 (December)

80.9

24.3

56.6

6.5

38.1

2021 (January)

84.4

25.3

59.1

6.5

37.7

2021 (February)

82.2

24.7

57.5

3.0

33.7

2021 (March)

84.9

25.5

59.4

3.0

33.6

 

The total return could be higher for those shareholders who were able to defer a capital gain on subscription and the net sum invested may be less.

* Dividends paid to C shareholders post conversion have been adjusted by the conversion ratio (0.85642528).

# Includes interim dividend of 3.0p per share payable10 September 2021.

 

Chairman's statement

The six months to 31 March 2021 saw strong performance from our AIM-traded investments, which provided a 31.0 per cent. return in the period. There was also positive progress from our unquoted investments, including the successful realisation of Ten10.

 

I am delighted to report that, during the period, the Company successfully raised £32.4m, before costs, through its largest offer for subscription in the history of the fund.

 

The Board is also pleased to declare an interim dividend of 3.0p to be paid on 10 September 2021. The dividend will be paid from realised capital profits generated from the sale of portfolio companies. 

 

Results

 

During the six months to 31 March 2021, the Company's NAV per share increased 18.4 per cent. from 70.2p to 83.1p after the payment of a final dividend of 3.5p per share on 5 March 2021. The table below shows this increase in NAV, which was due to a combination of a strong performance across the unquoted investments, AIM-traded investments and equity funds.

 

 

 

 

Pence per ordinary share

NAV as at 1 October 2020 (after deducting the final dividend of 3.5p)

70.2

Valuation increase (18.4 per cent.)

12.9

NAV as at 31 March 2021

83.1

 

 

The 30 April 2021 NAV was 87.8p, a 5.7 per cent. increase driven by further uplifts in the value of the quoted portfolio during the month.

 

Portfolio review

The table below provides a summary of each asset class and the return generated during the period under review.

 

Results

 

Asset class

NAV

(£m)

% of NAV*

Number of investees**

% return in the period***

Unquoted

52

22

35

12

AIM and LSE-traded companies

94

40

42

31

LF Gresham House UK Micro Cap Fund

31

13

48

32

LF Gresham House UK Multi Cap Income Fund

4

2

47

15

LF Gresham House UK Smaller Companies Fund

4

2

48

40

Liquid assets#

52

21

-

-

Total

237

100

-

-

 

*By value at 31 March 2021.
**Includes investee companies with holdings by more than one fund. Total number of individual companies held is 178.
***Return includes interest received on unquoted realisations during the period.

#Represents cash, OEICs and net current assets.

 

The value of the unquoted portfolio increased 12.4 per cent. in the six months to 31 March 2021. Continued trading momentum in software and e-commerce investments, together with a bounce back in demand within several businesses initially impacted by COVID-19, drove the portfolio performance. The gains recognised in these assets were partially offset by write downs in investments operating in the consumer, travel, or housing markets, which are still being negatively impacted by lockdown and

travel restrictions.

 

Public markets have continued to recover from lows 12 months ago, driven by the speed of the vaccination rollout, growth in economic activity and further Government support and investment programmes. Healthcare, education and technology investments were the key contributors to the strong performance of the direct AIM investments and the Equity Fund portfolios over the period. The AIM portfolio recorded growth of 31.0 per cent. in the period, outperforming relevant comparable indices, while the Micro Cap Fund, Multi Cap Income Fund and Smaller Companies Fund grew in value by 32.2, 15.0 and 40.1 per cent. over the period respectively.

 

Investments and Divestments

 

The Company's investments and divestments during the period are set out in the tables below.

 

 

Investments

 

I am pleased to report that the Company made four new investments totalling £5.6m and three follow-on investments with a combined value of £1.7m in the six months to 31 March 2021. Below are descriptions of the new investments made:

 

·     eConsult (unquoted) develops and operates a digital consultation platform used in both GP surgeries and hospitals.

·    RevLifter (unquoted) provides software that helps e-commerce companies optimise website conversion by offering tailored promotions to customers by using advanced behavioural analytics.

·     Counting Up (unquoted) is the leading UK provider of unified banking and accounting software to micro-businesses. Counting Up develops and operates the software which provides an all-in-one financial tool for small business users.

·     Metrion Biosciences (unquoted) is a UK-based Contract Research Organisation focused on delivering a range of high-quality ion channel drug discovery services.

 

Following the period end, a new quoted investment of £0.7m was made into Crimson Tide, a workforce management software-as-a-service provider.

 

The Investment Manager performs an assessment of environmental, social and governance ("ESG") factors and stewardship responsibilities in the selection of new investments and continues to monitor ESG considerations in its existing portfolio.

 

Realisations

 

Proceeds of £2.6m were received during the period from sales of quoted investments, including:

 

·     Cerillion plc - we reduced the position size by £1.9m, realising 4.2x the original sum invested.

·     Collagen Solutions plc - a full exit through a takeover offer for the company. The portfolio received £0.7m from the exit, realising 1.3x the original sum invested.

 

There continues to be good levels of liquidity in public markets and the Investment Manager has made a select number of divestments within the quoted portfolio where share prices have rallied strongly since the initial decline in markets, following the first national lockdown in March last year.

 

From the unquoted portfolio, the sale of the investment in Ten10 successfully completed in October 2020. The sale returned total proceeds of £7.3m resulting in a total money multiple of 3.7x original investment cost.

 

Following the end of the financial period there has been a takeover of Wey Education, resulting in the full realisation of the Company's investment, returning 13.6x cost and delivering proceeds of £7.1m.

 

 

COVID-19 impact

 

COVID-19 has had a material impact on UK businesses over the last year and has caused significant volatility and disruption to the global economy. The pandemic has presented operational risks for the Company, but these have been well managed and the Board continues to be pleased by the response and resilience of key service providers during this difficult time.

 

Although there are now several approved vaccines in circulation, there is still the risk of another wave of infections, which could lead to a further period of uncertainty and volatility in markets. We are encouraged by the Manager's ongoing engagement with portfolio companies and the focus on investing in businesses with strong fundamental characteristics which should continue to grow consistently through the economic cycle.

 

Dividends

 

The Board is pleased to declare an interim dividend of 3.0p per share for the year to 30 September 2021. This will be paid on 10 September 2021 to shareholders on the register as of 13 August 2021.

 

I must of course remind shareholders that the payment date and the amount of future dividends depends on the level and timing of profitable realisations and cannot be guaranteed.

 

Fundraising

 

During the period, the Company successfully raised £32.4m (before costs) through an offer for subscription which became fully subscribed in March 2021. The Directors are pleased to welcome the 1,000 new shareholders who invested for the first time and to thank the 940 existing shareholders who continue to support the Company.

 

The Board will consider whether to raise new funds in the 2021/22 tax year which will be determined by the Company's cashflow and its anticipated requirements to fund new investments over the next two. The Board appreciates that shareholders would like as much notice as possible of its fundraising intentions and will ensure that shareholders are informed as soon as possible.

 

Change of auditor

 

The audit and risk committee has considered the external audit arrangements and has held an audit tender process in early 2021. Following the conclusion of this process, the audit committee has appointed BDO LLP as the Company's auditor and KPMG LLP will retire with effect from 28 May 2021. KPMG's resignation letter will be sent to the Company's shareholders alongside this half-yearly report.

 

Director changes

 

We are pleased to have appointed Graham McDonald as a new independent Non-Executive Director at the Company's Annual General Meeting in February 2021. Graham was the former Global Head of Private Equity and Venture Capital at Aberdeen Standard Investments and we believe that his extensive private equity experience and market knowledge will be invaluable to our Company.

 

Shareholder scam warning

 

We are aware that some of our shareholders have received unsolicited phone calls or correspondence concerning their investment in the Company.

 

Shareholders are advised to be very wary of any unsolicited advice, offers to buy shares at a discount or offers for free company reports.

 

Please note that none of the Investment Manager, Company or the Company's Registrar, Computershare, would make unsolicited telephone calls to shareholders. Any calls made would relate only to official documentation already circulated to shareholders and never in respect of investment "advice".

 

If you are in any doubt about the veracity of an unsolicited phone call, please call either the Company or the Registrar at the numbers provided below. 

 

Outlook

 

The economic outlook in the UK continues to improve as COVID-19  restrictions ease and consumer confidence recovers. The March Budget also included an extension of Government support and investment in infrastructure and the technology sector to help rebuild the UK economy. While most economic commentators expect the economy to rebound strongly over the next two quarters, the longer-term impact of the pandemic remains uncertain. Any additional wave of the virus could lead to the reintroduction of restrictions and the possibility of further volatility in both public markets and revenues within some portfolio companies. However, the Board continues to believe that the portfolio is well positioned to deliver robust investment performance over the long-term and the Company remains well capitalised to actively support the high growth, entrepreneurial businesses which will be key in driving a sustainable economic recovery.

 

 

Sarah Fromson

Chairman

 

27 May 2021

 

Investments in the period

 

Company

Location

Sector

Activity

Book cost

£'000

Unquoted investments

New

eConsult Ltd

Surrey

Healthcare & Education

Online consultation provider used by GP practices and hospitals

2,599

Metrion Biosciences Ltd

Cambridge

Healthcare & Education

Ion channel drug discovery and safety assessment services provider

1,192

Counting Ltd

London

Business Services

Banking and accounting software for small business

1,059

Revlifter Ltd

London

TMT

A-I platform using advanced behavioural analytics to deliver tailored promotions to users

779

Follow On

Glisser Ltd

London

Business Services

Audience engagement software

794

Equipsme (Holdings) Ltd

London

SME health insurance plans provider

238

Total unquoted investments

6,661

AIM-traded investments

Follow on

CloudCall Group plc

Leicester

TMT

Cloud software and integrated communications

606

Total AIM-traded investments

606

Total investments in the period

7,267

 

 

 

Realisations in the period

 

Company

 

First

investment

date

Original book cost£'000

Proceeds

£'000

Overall

multiple

return

Unquoted realisations

Ten10 Group Limited

Full trade sale

Feb 15

2,331

7,254

3.7*

Total unquoted realisations

 

 

2,331

7,254

3.7*

AIM-traded realisations

Cerillion plc

Market sale

Nov 15

460

1,924

4.2

Collagen Solutions plc

Takeover

Mar 17

551

716

1.3

Total AIM-traded realisations

 

 

1,011

2,640

2.6

Total realisations in the period

 

 

3,342

9,894

3.0

 

Residual book cost at realisation date.

Proceeds at time of realisation including interest.

*Includes interest/dividends received, loan note redemptions and partial realisations accounted for in prior periods.

             

 

Responsibility statement of the directors in respect of the half-yearly financial report

 

Half-yearly report

 

The important events that have occurred during the period under review, the key factors influencing the financial statements and the principal uncertainties for the remaining six months of the financial year are set out in the Chairman's Statement and the Strategic Report.

 

The principal risks facing the Company are substantially unchanged since the date of the Company's Annual Report for the financial year ended 30 September 2020 and continue to be as set out in that Report on pages 18 and 19.

 

Risks faced by the Company include but are not limited to; loss of approval as a Venture Capital Trust, investment performance risk, legislative risk, regulatory and compliance risk, operational risk, and economic and political risk. The Board considers the COVID-19 pandemic and Brexit to be factors which permeate these risks, and their impact is considered within the relevant risk within the Annual Report.

 

Responsibility statement

 

Each director confirms that to the best of our knowledge:

·   the condensed set of nancial statements has been prepared in accordance with FRS 104 Interim Financial Reporting Standards and gives a true and fair view of the assets, liabilities, financial position and profit or loss of the Company.

 

·      This half-yearly report includes a fair review of the information required by:
 

a)   DTR 4.2.7R of the Disclosure Guidance and Transparency Rules, being an indication of important events that have occurred during the rst six months of the nancial year and their impact on the condensed set of nancial statements; and a description of the principal risks and uncertainties for the remaining six months of the year; and

 

b)   DTR 4.2.8R of the Disclosure Guidance and Transparency Rules, being related party transactions that have taken place in the rst six months of the current nancial year and that have materially affected the nancial position or performance of the entity during that period; and any changes in the related party transactions described in the last annual report that could do so.

 

The half-yearly report was approved by the Board of Directors on 27 May 2021 and was signed on its behalf by Ms Sarah Fromson, Chairman.

 

 

 

 

Sarah Fromson

Chairman

27 May 2021

 

 

 

Condensed Income Statement

For the six months to 31 March 2021 (Unaudited)

 

 

 

Notes

Six months to
31 March 2021

Six months to
31 March 2020

Year to
30 September 2020

Revenue

£'000

Capital

£'000

Total

£'000

Revenue

£'000

Capital

£'000

Total

£'000

     

Revenue

£'000

Capital

£'000

Total

£'000

Gains/(losses) on investments

5

-

37,141

37,141

-

(15,852)

(15,852)

-

8,680

8,680

Income

 

566

-

566

519

-

519

4,008

-

4,008

Investment management fee

 

(661)

(1,983)

(2,644)

(529)

(1,586)

(2,115)

(1,078)

(3,235)

(4,313)

Other expenses

 

(377)

-

(377)

(362)

-

(362)

(674)

-

(674)

(Loss)/profit  before taxation

 

(472)

35,158

34,686

(372)

(17,438)

(17,810)

2,256

5,445

7,701

Taxation on ordinary activities

 

-

-

-

-

-

-

(275)

275

-

(Loss)/profit for the period, being the total comprehensive income for the period after taxation

 

(472)

35,158

34,686

(372)

(17,438)

(17,810)

1,981

5,720

7,701

Return per ordinary share:

 

 

 

 

 

 

 

 

 

 

Basic and Diluted

2

(0.18p)

13.23p

13.05p

(0.16p)

(7.35p)

(7.51p)

0.82p

2.36p

3.18p

 

All items in the above statement derive from continuing operations.

 

There are no recognised gains and losses other than those disclosed in the Income Statement.

 

The revenue column of the Income Statement includes all income and expenses. The capital column accounts for the realised and unrealised profit or loss on investments and the proportion of the management fee charged to capital.

 

The total column of this statement is the unaudited Statement of Total Comprehensive Income of the Company prepared in accordance with the Financial Reporting Standard ("FRS"). The supplementary revenue return and capital return columns are prepared in accordance with the Statement of Recommended Practice issued by the Association of Investment Companies ("AIC SORP").

 

 

 

Condensed Statement of Changes in Equity

For the six months to 31 March 2021 (Unaudited)

 

 

 

Non-distributable reserves

Distributable Reserves

 

Notes

Called-up share capital

£'000

Share
premium
£'000

Revaluation

reserve

£'000

Capital
reserve

 £'000

Revenue

reserve

£'000

Total

£'000

At 1 October 2020

 

27,146

46,775

30,890

75,290

2,216

182,317

Profit/(loss) after taxation

 

-

-

31,462

3,696

(472)

34,686

Net proceeds of share issues, share buybacks & sale of shares from treasury

3

4,060

27,459

-

(1,608)

-

29,911

Dividends paid

4

-

-

-

(8,354)

(1,232)

(9,586)

At 31 March 2021

 

31,206

74,234

62,352

69,024

512

237,328

 

For the six months to 31 March 2020 (Unaudited)

 

 

 

Non-distributable reserves

Distributable Reserves

 

Notes

Called-up share capital

£'000

Share
premium

£'000

Revaluation

reserve

£'000

Capital

reserve
£'000

Revenue

reserve

£'000

Total

£'000

At 1 October 2019

 

24,802

31,191

25,492

92,316

1,575

175,376

Loss after taxation

 

-

-

(13,985)

(3,453)

(372)

(17,810)

Net proceeds of share issues & share buybacks

 

2,345

15,584

-

(1,911)

-

16,018

Dividends paid

 

-

-

-

(7,407)

(1,093)

(8,500)

At 31 March 2020

 

27,147

46,775

11,507

79,545

110

165,084

 

 

For the year ended 30 September 2020 (Audited)

 

 

 

 

Non-distributable reserves

Distributable reserves

 

Notes

Called-up share capital

£'000

Share
premium

£'000

Revaluation

reserve

£'000

Capital
reserve

£'000

Revenue

reserve

£'000

Total

£'000

At 1 October 2019

 

24,802

31,191

25,492

92,316

1,575

175,376

Profit after taxation

 

-

-

5,398

322

1,981

7,701

 

2,344

15,584

-

(2,782)

-

15,146

Other costs charged to capital

 

-

-

-

(1)

-

(1)

Dividends paid

 

-

-

-

(14,565)

(1,340)

15,905)

At 30 September 2020

 

27,146

46,775

30,890

75,290

2,216

182,317

 

 

 

 

 

Condensed Balance Sheet

As at 31 March 2021 (Unaudited)

 

                                                                                                        

Notes

 

As at

31 March

2021

£'000

As at

31 March

2020

£'000

As at
30 September 2020

£'000

Fixed assets

 

 

 

 

Unquoted investments                                                                        

5

52,113

45,107

46,442

Traded on AIM                                                                                    

5

94,364

61,218

74,081

Collective investment vehicles                                                              

5

54,503

46,317

59,367

Listed on LSE

5

36

-

42

Investments                                              

5

201,016

152,642

179,932

Current assets

 

 

 

 

Debtors

 

110

2,258

571

Cash at bank

 

37,767

11,543

3,108

 

 

37,877

13,801

3,679

Creditors (amounts falling due within one year)

 

(1,565)

(1,359)

(1,294)

Net current assets

 

36,312

12,422

2,385

Net assets

 

237,328

165,084

182,317

Capital and reserves

 

 

 

 

Called-up share capital

 

31,206

27,147

27,146

Share premium

 

74,234

46,775

46,775

Capital reserve

 

69,024

79,545

75,290

Revaluation reserve                                                                           

5

62,352

11,507

30,890

Revenue reserve

 

512

110

2,216

Equity shareholders' funds

 

237,328

165,084

182,317

 

 

 

 

 

Net asset value per share

 

83.07p

66.44p

73.74p

Number of ordinary shares in circulation

 

258,692,452

248,485,874

247,251,570

 

 

Condensed Statement of cash flows

For the six months to 31 March 2021 (Unaudited)           

 

 

 

Six
months to

31 March 2021

£'000

Six
months to

31 March 2020

£'000

Year to
30 September 2020

£'000

Net cash outflow from operating activities

(1,670)

(1,919)

(1,339)

Net cash inflow/(outflow) from investing activities

16,050

(3,127)

(6,023)

Equity dividends paid

(9,586)

(8,500)

(15,905)

Net cash inflow/(outflow) before financing activities

4,794

(13,546)

(23,267)

Net cash inflow from financing activities

29,865

14,097

15,383

Increase/(decrease) in cash

34,659

551

(7,884)

Reconciliation of net cash flow to movement in net cash

 

 

 

Increase/(decrease) in cash

34,659

551

(7,884)

Opening cash at bank and on deposit

3,108

10,992

10,992

Closing cash at bank and on deposit

37,767

11,543

3,108

Reconciliation of profit/(loss) before taxation to net cash outflow from operating activities

 

 

 

Profit/(loss) before taxation

34,686

(17,810)

7,701

Gains/(losses) on investments

(37,141)

15,852

(8,680)

Changes in working capital and other non-cash items

785

39

(360)

Net cash outflow from operating activities

(1,670)

(1,919)

(1,339)

 

 

Notes to the financial statements

 

For the six months to 31 March 2021 (Unaudited)

 

1.         Basis of preparation

 

The condensed financial statements for the six months to 31 March 2021 comprise the unaudited financial statements together with the related notes. The Company applies FRS 102 and the AIC's Statement of Recommended Practice ('the SORP') for its annual Financial Statements. The condensed financial statements for the six months to 31 March 2021 have therefore been prepared in accordance with FRS 104 'Interim Financial Reporting' and the principles of the SORP. They have been prepared on a going concern basis. The financial statements have been prepared on the same basis as the accounting policies set out in the Company's Annual Report and Financial Statements for the year ended 30 September 2020.

 

The financial information contained in this half-yearly financial report does not constitute statutory accounts as defined in sections 434 - 436 of the Companies Act 2006. The half-yearly financial report for the six months ended 31 March 2021 and for the six months ended 31 March 2020 have been neither audited nor reviewed by the Company's auditors. The information for the year to 30 September 2020 has been extracted from the latest published audited financial statements, which have been filed with the Registrar of Companies. The report of the auditor for the audited financial statements for the year to 30 September 2020 was: (i) unqualified; (ii) did not include a reference to any matters to which the auditor drew attention by way of emphasis without qualifying their report; and (iii) did not contain a statement under section 498 (2) or (3) of the Companies Act 2006. No statutory accounts in respect of any period after 30 September 2020 have been reported on by the Company's auditors or delivered to the Registrar of Companies.

 

Copies of the half-yearly financial report have been made available to shareholders and are available from Gresham House, Octagon Point, 5 Cheapside, London EC2V 6AA.

 

2.         Performance and shareholder returns

 

Return per share is based on a weighted average of 265,723,554 ordinary shares in issue (31 March 2020 - 237,173,550 ordinary shares; 30 September 2020 - 242,461,220 ordinary shares).

 

Earnings for the first six months to 31 March 2021 should not be taken as a guide to the results of the full financial year to 30 September 2021.

 

3.         Called-up share capital

 

The below table details the movement in called-up share capital during the period.

 

Allotted, called-up and fully paid:

 

Ordinary shares

£'000

252, 2271,466,654 ordinary shares of 10p each listed at 30 September 2020

27,146

40,593,158 ordinary shares of 10p each issued during the period

4,060

312,059,812 ordinary shares of 10p each listed at 31 March 2021

31,206

24,215,084 ordinary shares of 10p each held in treasury at 30 September 2020

(2,421)

2,672,276 ordinary shares of 10p each repurchased during the period and held in treasury

(268)

520,000 ordinary shares of 10p each sold from treasury during the period

52

26,367,360 ordinary shares of 10p each held in treasury at 31 March 2021

(2,637)

285,692,452 ordinary shares of 10p each in circulation* at 31 March 2021

28,569

*carrying one vote each

 

During the six months to 31 March 2021, the Company issued 40,593,158 shares at net proceeds of £31,515,000 (after costs). During the same period, the Company purchased 2,672,276 shares to be held in treasury at a cost of £2,005,000 (including costs). The Company also sold 520,000 shares from treasury for proceeds of £401,000. At 31 March 2021, the Company held 26,367,360 ordinary shares in treasury. Shares may be sold out of treasury below Net Asset Value as long as the discount at issue is narrower than the average discount at which the shares were bought into treasury.

 

Excluding treasury shares, there were 285,692,452 ordinary shares in issue at 31 March 2021 (31 March 2020 - 248,485,874 ordinary shares; 30 September 2020 - 247,251,570 ordinary shares).

 

4.         Dividends

 

The final dividend for the year ended 30 September 2020 of 3.5p per share (3.05p capital, 0.45p revenue) was paid on 5 March 2021 to shareholders on the register on 5 February 2021. The ex-dividend date was 4 February 2021.

 

During the year to 30 September 2020, the Company paid an interim dividend on 11 September 2020 of 3.0p per share (2.9p capital, 0.1p revenue).

 

 

5.         Investments

 

All investments are initially recognised subsequently measured at fair value. Changes in fair value are recognised in the Income Statement.

 

The methods of fair value measurement are classified into a hierarchy based on reliability of the information used to determine the valuation.

 

·      Level 1 - Fair value is measured based on quoted prices in an active market.

·     Level 2 - Fair value is measured based on directly observable current market prices or indirectly being derived from market prices.

·      Level 3 - Fair value is measured using a valuation technique that is not based on data from an observable market.

 

The valuation of unquoted investments contained within level 3 of the Fair Value hierarchy involves key assumptions dependent upon the valuation methodology used. The primary methodologies applied are:

 

-     Rebased Cost

-     Earnings Multiple

-     Offer Less 10 per cent.

 

The earnings multiple approach involves more subjective inputs than the Rebased Cost and Offer approaches and therefore presents a greater risk of over or under estimation. Key assumptions for the earnings multiple approach are the selection of comparable companies and the use of either historic or forecast revenue or earnings, as considered most appropriate. Other assumptions include the appropriateness of the discount magnitude applied for reduced liquidity and other qualitative factors. These assumptions are described in more detail in Note 2.3 in the Company's Report and Financial Statements for the year to 30 September 2020. The techniques used in the valuation of unquoted investments have not changed materially since the date of that report.   

 

 

 

Level 1

Level 2

Level 3

 

 

Traded

on AIM

£'000

 

Traded 

on AIM

£'000

 

Listed

on LSE

£'000

Collective

investment

vehicles

£'000

 

 

Unquoted

£'000

Total

£'000

Opening book cost

54,095

6,513

 

3,429

45,418

39,587

149,042

Opening unrealised appreciation/(depreciation)

17,433

(3,960)

(3,387)

13,949

6,855

30,890

Opening fair value

71,528

2,553

42

59,367

46,442

179,932

Movements in the period:

 

 

 

 

 

 

Transfer between levels

6,513

(6,513)

-

-

-

-

Purchases at cost

606

-

-

1,500

6,661

8,767

Sale - proceeds

(2,640)

-

-

(15,453)

(6,731)

(24,824)

 - realised gains/(losses) on sales

100

-

-

-

(2)

98

Unrealised gains realised during the year

1,481

-

-

-

4,100

5,581

Increase/(decrease) in unrealised appreciation/ (depreciation)

16,776

3,960

(6)

9,089

1,643

31,462

Closing fair value

94,364

-

36

54,503

52,113

201,016

Closing book cost

60,155

-

3,429

31,465

43,615

138,664

Closing unrealised appreciation/(depreciation)

34,209

-

(3,393)

23,038

8,498

62,352

Closing fair value

94,364

-

36

54,503

52,113

201,016

Equity shares

94,364

-

36

-

30,452

124,852

Preference Shares

-

-

-

-

7,864

7,864

Loan notes

-

-

-

-

13,797

13,797

Collective investment vehicles

-

-

-

54,503

-

54,503

Closing fair value

94,364

-

36

54,503

52,113

201,016

 

The AIM-traded investments held in Level 2 as at 30 September 2020 have been transferred to Level 1 after recent trading activity in the period.

 

6.         Other required disclosures

6.1        Segmental reporting

 

The Company has one reportable segment being investing in primarily a portfolio of UK growth businesses, whether unquoted or traded on AIM.

 

6.2           Principal risks and uncertainties

 

The Company's assets consist of equity and fixed interest investments, shares in collective investment schemes, cash and liquid resources. Its principal risks are therefore market risk, price risk, credit risk and liquidity risk. Other risks faced by the Company include loss of approval as a Venture Capital Trust, legislative, investment performance, economic, political and other external factors, regulatory and compliance and operational risks. These risks, and the way in which they are managed, are described in more detail in the Principal Risks & Uncertainties table within the Strategic Report section in the Company's Annual Report and Accounts for the year to 30 September 2020. The Board continues to regularly review the risk environment in which the Company operates.

 

The COVID-19 pandemic has presented the Company with immediate risks in respect of the performance and valuation of portfolio companies and operational risks such as the resilience of third party providers. These risks are discussed further in the Chairman's statement.

 

6.3          Related parties

 

Gresham House Asset Management Ltd ('the Manager') manages the investments of the Company. The Manager also provides or procures the provision of secretarial, accounting, administrative and custodian services to the Company. Under the management agreement, the Manager receives a fee of 2.5 per cent. per annum of the net assets of the Company. This is described in more detail under the heading 'The Management Agreement' within the Strategic Report in the Company's Annual Report and Accounts for the year ended 30 September 2020. During the period the Company has incurred management fees of £2,644,000 (31 March 2020 - £2,115,000; 30 September 2020 - £4,313,000) and secretarial and accounting fees of £71,000 (31 March 2020 - £87,000; 30 September 2020 - £175,000) payable to the Manager. No performance fee has been accrued at 31 March 2021 (31 March 2020 - £nil; 30 September 2020 - £nil). This is described in more detail under the heading 'Performance fees' within the Strategic Report in the Company's Annual Report and Financial Statements for the year to 30 September 2020.

 

A related party relationship exists between Baronsmead Second Venture Trust and Happy Days Consultancy Limited, owing to the significant influence deemed to be held over the operations of the company. As at 31 March 2021, the loan balance stood at £6,617,000, including £2,855,000 of capitalised interest, as provided for in the Agreement with the company.

 

A related party relationship exists between Baronsmead Venture Trust and Storyshare Holdings Limited, owing to the significant influence held over the operations of the company.

 

6.4          Investment in associates

 

The Company has made the presumption that the following holdings are investments in associates, owing to the proportion of equity held and representation on the board representing significant influence over the operations of the company. The investments held are held as part of an investment portfolio, and are therefore measured at fair value through profit and loss, as detailed in note 7 rather than using the equity method, as permitted by Section 14 of FRS 102:

 

 

Name

Location

Class of Shares held

% of Equity

Profit (£m)

Net Assets (£m)

Results for year ended

Happy Days Consultancy

UK

A Ordinary

30.8

(1.3)

(9.7)

31 December 20191

 

1Latest published set of financial statements available at Companies House.

 

 

6.5          Going Concern

 

The Board has considered a detailed assessment of the company's ability to meet its liabilities as they fall due, including stress and liquidity tests which modelled the effects of substantial falls in markets and significant reductions in market liquidity (including further stressing the current economic conditions caused by the COVID-19 pandemic) on the Company's assets and liabilities. In light of the results of these tests, the Company's cash balances, the liquidity of the Company's investments and the absence of any gearing, the Directors are satisfied that the Company has adequate financial resources to continue in operation for at least the next 12 months and that, accordingly, it is appropriate to adopt the going concern basis in preparing the financial statements.

 

6.6          Post balance sheet events

 

The following events occurred between the balance sheet date and the signing of these financial statements:

 

·     The 30 April 2021 NAV of 87.8p was announced on 07 May 2021. At the date of publishing this report, the Board is unaware of any matter that will have caused the NAV per share to have changed significantly since the latest NAV.

·     Full realisation: a takeover of Wey Education completed on 25 May 2021, realising proceeds of £7.1m and returning 13.6x invested cost.

  

 

Corporate Information

 

Directors

Sarah Fromson (Chair)†

Malcolm Groat*

Graham McDonald

Tim Farazmand#

 

Secretary

Gresham House Asset Management Ltd

 

Registered Office

5 New Street Square

London EC41 3TW

 

Investment Manager

Gresham House Asset Management Ltd

5 New Street Square

London EC41 3TW

020 3875 9862

 

Registered Number

04115341

 

 

 

 

 

 

 

 

 

 

 

 

† Chair of the Nomination Committee.

* Senior Independent Director and Chairman of the Audit & Risk Committee.

#Chairman of the Management Engagement and Remuneration Committee.

 

Registrars and Transfer Office

Computershare Investor Services PLC

The Pavilions

Bridgwater Road

Bristol BS99 6ZZ

Tel: 0800 923 1534

 

Brokers

Panmure Gordon & Co

One New Change

London EC4M 9AF

Tel: 020 7886 2500

 

Auditor

BDO LLP

55 Baker Street

London

W1U 7EU

 

 

Solicitors

Dickson Minto W.S.

Broadgate Tower

20 Primrose Street

London EC2A 2EW

 

VCT Status Adviser

PricewaterhouseCoopers LLP

1 Embankment Place

London WC2N 6RH

 

Website

www.baronsmeadvcts.co.uk

 

 

 

 

LEI 2138008D3WUMF6TW8C28

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR BSGDUGXDDGBR